| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Nov | ||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
Pharmacy Drugs
Recent Posts
- Democrats Push Medical Device Liability Bill
- FDA Investigates Heparin Link in Two Delaware Deaths
- Conflict Of Interest Reported In 29 Percent Of Cancer Studies
- Interim Results Of Abbott’s PROGRESS Study Show Rapid Viral Decline In Dual-Therapy Regimen Of Kaletra(R) (lopinavir/ritonavir) And Raltegravir
- Survival For Prostate Cancer Patients Younger Than 50 Improved By Surgery
Random Posts
- Medtronic Issues Pacemaker Recall
- Prereg Tutor Training Day And Prereg Trainee Pharmacist Programme 2009/10 - Booking Now
- Zetiq Reports Success In Clinical Trial Aimed For Early Identification Of Cervical Cancer
- FDA Approves Implant for Retinal Vein Occlusion
- Versartis Presents Preclinical Data For Novel Type 2 Diabetes Drug
- Excess Body Weight Causes Over 124,000 New Cancers A Year In Europe
- First-Ever Drug Effectiveness Study On College Students With ADHD
- Aegerion Pharmaceuticals Announces Final Lomitapide (AEGR-733) Phase II Data
- Heart Attack Damage May Be Reduced By New Drug
- Affymax Reports Phase 2 Clinical Trial Data Supporting Hemoglobin Increases With Once-Per-Month Hematide Regardless Of Patient Baseline Renal Function
Potentially Dangerous Drug Interactions Missed By Prescribers
Posted by: admin in Pharmacy Drugs on August 29th, 2009
Research led by The University of Arizona College of Pharmacy has found that medication prescribers correctly identified fewer than half of drug pairs with potentially dangerous drug-drug interactions.
These findings raise concern because of the high number of drugs Americans take: an average of 2.3 medications is prescribed during each physician office visit.
A synopsis of the research was published in May Research Activities, a digest of research findings intended to contribute to the national policymaking process.
The researchers, led by Daniel Malone, PhD, professor at the UA College of Pharmacy, mailed a questionnaire to 12,500 U.S. prescribers who were selected based on a history of prescribing drugs associated with known potential for drug-drug interaction. Prescribers were primarily physicians, physicians’ assistants and nurse practitioners.
Recipients were asked to classify 14 drug pairs as “contraindicated,” “may be used together but with monitoring” or “no interaction.” Respondents could also state that they were “not sure.”
For the drug pairs, one commonly prescribed medication was matched with another commonly prescribed medication.
The 950 respondents classified 42.7 percent of all drug combinations correctly.
Of the 14 drug pairs presented, four of them were contraindicated, meaning they should not be used together. A majority of prescribers correctly identified only one of the four pairs as contraindicated.
Moreover, for half of the 14 drug pairs, more than one-third of the respondents answered that they were “not sure,” and two of these drug pairs were contraindicated.
“The study found a very low rate of recognition of these particular interactions,” says Malone, “and some of these interactions are very common.”
Use of several of the contraindicated drug pairs could be dangerous. For example, taking sildenafil (Viagra®) and nitrates, such as isosorbide mononitrate, can be life-threatening.
According to Malone, the research indicates that health professional programs are not doing enough to teach students about potential drug-drug interactions. Consequently, patients should be sure to tell their pharmacist of all the medications they are taking.
Source:
Karin Lorentzen
University of Arizona, College of Pharmacy
View drug information on Viagra.